Previous 10 | Next 10 |
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 12:45 p.m. ET. A live audio webcast wil...
Summary Elanco Animal Health, an Eli Lilly spin-off, is the second-largest pure-play in the industry. Acquisitions to achieve critical mass resulted in a protracted period of restructuring, reorganization and poor financial performance. Elanco's tangible equity units (NYSE: ELAT) of...
Today Elanco Animal Health (NYSE:ELAN) announced the U.S. Food and Drug Administration (FDA) approved Bexacat™ (bexagliflozin tablets), the first orally administered prescription medication to improve glycemic control in cats with diabetes mellitus, expanding Elanco’s innovative fel...
The U.S. Food and Drug Administration (FDA) announced Thursday the approval of Bexacat tablets developed by Elanco Animal Health Incorporated ( NYSE: ELAN ) for diabetes mellitus in cats. Accordingly, Bexacat will be indicated in the U.S. to improve glycemic control “in otherwi...
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Evercore ISI 5 th Annual HealthCONx Conference on Tuesday, November 29, 2022. Jeff Simmons, president and CEO, will participate in a fireside chat at 8:50 a.m., Eastern time. A live audio webcast will be avai...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Elanco ( NYSE: ELAN ) rose 5.5% on speculation that the animal health company could be a possible activist target. Olin's ( OLN ) announcement on Thursday that Scott Ferguson, head of activist fund Sachem Head, was leaving the board may give the investor time to ...
Image source: The Motley Fool. Elanco Animal Health Inc. (NYSE: ELAN) Q3 2022 Earnings Call Nov 08, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Elanco Animal Health Inc. (ELAN) Q3 2022 Earnings Call Transcript ...
Elanco Animal Health Incorporated (ELAN) Q3 2022 Earnings Conference Call November 08, 2022 08:00 AM ET Company Participants Katy Grissom - Head of Investor Relations Jeff Simmons - President & Chief Executive Officer Ellen de Brabander - Executive Vice Presi...
The following slide deck was published by Elanco Animal Health Incorporated in conjunction with their 2022 Q3 earnings call. For further details see: Elanco Animal Health Incorporated 2022 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Feeding dairy cows Bovaer® (3-NOP), Elanco's newest feed ingredient , provides a scalable and credible way for dairy farmers to benefit from being good stewards of the environment by being financially rewarded for implementing on-farm sustaina...
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement PR Newswire GREENFIELD, Ind. , July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on ...
SAN FRANCISCO, CA / ACCESSWIRE / July 17, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE:ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...